Oneview Healthcare PLC (ASX: ONE) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Oneview Healthcare PLC Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $184.22 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 449.95 million
Earnings per share -0.028
Dividend per share N/A
Year To Date Return 844.44%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Oneview Healthcare PLC (ASX: ONE)
Latest News

ONE ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Oneview Healthcare PLC

Oneview Healthcare PLC provides patient engagement and clinical workflow technology solutions to healthcare facilities. It provides various solutions such as Inpatient Solution, Outpatient Solution, Clinical Pathways, and others. The company generates its revenue in the form of software usage and content revenue, support services, and license fee. Geographically the company operates in Ireland, the United States, Australia, and the Middle East, and North Africa. Generating,a majority of its revenue from the United States.

ONE Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
17 Sep 2021 $0.43 $0.04 10.26% 2,507,732 $0.39 $0.44 $0.39
16 Sep 2021 $0.39 $0.01 2.63% 358,921 $0.38 $0.40 $0.38
15 Sep 2021 $0.38 $-0.02 -5.06% 1,263,557 $0.40 $0.42 $0.38
14 Sep 2021 $0.40 $0.02 5.33% 2,239,906 $0.38 $0.41 $0.38
13 Sep 2021 $0.38 $-0.01 -2.63% 383,980 $0.38 $0.38 $0.37
10 Sep 2021 $0.38 $0.03 8.45% 408,909 $0.36 $0.38 $0.36
09 Sep 2021 $0.36 $-0.02 -5.41% 459,627 $0.37 $0.37 $0.36
08 Sep 2021 $0.37 $0.00 0.00% 286,936 $0.37 $0.38 $0.37
07 Sep 2021 $0.37 $-0.01 -2.63% 303,884 $0.38 $0.38 $0.37
06 Sep 2021 $0.38 $0.00 0.00% 401,298 $0.38 $0.39 $0.37
03 Sep 2021 $0.38 $0.00 0.00% 400,306 $0.38 $0.38 $0.37
02 Sep 2021 $0.38 $-0.01 -2.60% 763,505 $0.38 $0.38 $0.37
01 Sep 2021 $0.39 $0.01 2.63% 299,830 $0.38 $0.39 $0.38
31 Aug 2021 $0.38 $-0.02 -5.06% 786,729 $0.40 $0.40 $0.38
30 Aug 2021 $0.40 $0.03 8.22% 4,461,739 $0.33 $0.40 $0.32
27 Aug 2021 $0.37 $0.02 5.71% 925,520 $0.35 $0.37 $0.35
26 Aug 2021 $0.35 $0.03 9.38% 802,018 $0.32 $0.36 $0.32
25 Aug 2021 $0.32 $0.00 0.00% 380,546 $0.32 $0.33 $0.32
24 Aug 2021 $0.32 $-0.01 -3.03% 744,382 $0.33 $0.33 $0.32
23 Aug 2021 $0.33 $0.00 0.00% 533,989 $0.33 $0.34 $0.33
20 Aug 2021 $0.33 $-0.01 -2.94% 608,125 $0.34 $0.35 $0.33
19 Aug 2021 $0.34 $0.00 0.00% 516,430 $0.35 $0.35 $0.34

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
18 Dec 2020 James Fitter Issued 6 $269,859
Rights issue. CDI's
18 Dec 2020 Joseph Rooney Issued 1 $71,830
Rights issue. CDI's
18 Dec 2020 Lyle Berkowitz Issued 410 $16,406
Rights issue. CDI's
18 Dec 2020 Michael Kaminski Issued 717 $28,706
Rights issue. CDI's
30 Nov 2020 Lyle Berkowitz Buy 50 $2,500
Exercise of options. CDI's
30 Nov 2020 Lyle Berkowitz Exercise 50 $2,500
Exercise of options.
25 Sep 2020 Michael Kaminski Buy 294 $14,706
Conversion of securities. CDI's
Estimated valuation.
As per announcement on 29/09/2020.
There is no transaction reported for Vesting of restricted share unit awards.
25 Sep 2020 Lyle Berkowitz Buy 294 $14,706
Conversion of securities. CDI's
Estimated valuation.
As per announcement on 29/09/2020.
There is no transaction reported for Vesting of restricted share unit awards.
25 Sep 2020 Joseph Rooney Buy 588 $29,412
Conversion of securities. CDI's
Estimated valuation.
As per announcement on 29/09/2020.
There is no transaction reported for Vesting of restricted share unit awards.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr James Fitter Chief Executive OfficerExecutive Director Jan 2013
Mr Fitter has over 25 years experience in the global financial markets. James founded and managed an independent asset management Company and spent over ten years as a professional investor and an independent advisor.
Mr Joseph Rooney Non-Executive Director Feb 2016
Mr Rooney is Chair of Fundraising for the Clongowes Wood College Foundation. Until the end of 2012, Joseph was a partner and global strategist at Autonomy Capital Research LLP. Prior to this, he held a number of senior positions at Lehman Brothers Inc, including Managing Director, Head of Global Strategy and trustee of their UK pension fund.
Lyle Berkowitz Non-Executive Director Sep 2016
Dr Berkowitz is an experienced digital health advisor and investor. He has over 25 years experience as a primary care physician, an informatician, a healthcare innovator and a health tech entrepreneur. For over 20 years, Dr Berkowitz helped lead IT and Innovation at Northwestern Medicine in Chicago, a top 15 healthcare system. In addition, he has helped start and manage range of healthcare technology companies over the years, including serving as a top executive at MDLIVE, one of the telehealth companies in the world; and Chairman of the board at healthfinch. As CEO of Back 9 Healthcare Consulting, he consults and speaks globally on healthcare IT and innovation, is Editor-in Chief of Telehealth & Medicine Today and author of Innovation with Information Technologies in Healthcare. He is an Associate Professor of Clinical Medicine at the Feinberg School of Medicine at Northwestern University.
Mr Michael Kaminski Non-Executive DirectorNon-Executive Chairman Aug 2018
Mr Kaminski is a senior healthcare executive with over 35 years of experience in innovative technology-based companies. He has a track record operating across range of stages of the business cycle from start-up entrepreneurial organisations to global enterprises. Michael is currently serving as President and CEO of Linet Americas, prior to this he was the CEO of Landauer Inc.
Ms Nashina Asaria Non-Executive Director May 2021
Ms Asaria has experience in digital health and virtual care having had leadership, investor and advisor roles with numerous digital health and SaaS companies. Nashina is currently an Independent Board Member and Chief Product Officer for Cloudbreak Health LLC, a US telehealth company. She also has experience in international partnerships, business strategies, business development, product management, marketing and deployment. As a Board Member of Cloudbreak Health, as well as its Chief Product Officer, she is responsible for Product Marketing, Product Management and Requirements, UI design, Software Engineering, Implementation and Customer Experience. Most recently, Nashina was Co-Founder & Partner of Lumini Partners focused on bringing circular economy and energy solutions to Southern Africa. Prior to this, Nashina was the Chief Commercial Officer for LifeQ, a provider of biometrics and health information derived from wearable devices used in the insurance, health and pharma industries. Nashina has also held leadership roles with Verifone, Nantworks and Qualcomm.
Ms Helena D'Arcy Acting Chief Financial Officer and Company Secretary Jul 2020
-
Helena D'Arcy Acting Chief Financial Officer and Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
UBS Nominees Pty Ltd 61,321,030 15.30%
HSBC Custody Nominees (Australia) Limited 48,965,594 12.20%
HSBC Custody Nominees (Australia) Limited GSCO ECA 25,215,043 6.30%
Mark McCloskey 16,300,248 4.10%
Walling Pty Ltd <CJ Howard Super Fund A/C> 13,500,000 3.40%
HSBC Custody Nominees (Australia) Limited A/C 2 12,112,397 3.00%
Alfred Global Holdings Pty Limited <Messara Family A/C> 11,175,504 2.80%
James Fitter 9,865,734 2.50%
HSBC Custody Nominees (Australia) Limited i 9,000,000 2.30%
Manderrah Pty Limited 8,620,830 2.20%
Freshwater Superannuation Pty Limited <William Vicars S/F A/C> 7,976,767 2.00%
AJA Investments Pty Ltd <The Oliver Amelia Prop A/C> 5,731,545 1.40%
BNP Paribas Nominees Pty Ltd Six Sis Ltd <Drp A/C> 5,097,192 1.30%
OV No.1 Pty Ltd <The Ov A/C>1 4,210,798 1.10%
Citicorp Nominees Pty Limited 4,170,039 1.00%
Golden Growth Limited 3,600,000 0.90%
Joseph Rooney 3,591,498 0.90%
Comsec Nominees Pty Limited 3,540,389 0.90%
Longbridge Nominees Pty Limited <Longbridge A/C> 3,478,434 0.90%
CJH Holdings Pty Limited <CJ Howard S/F A/C> 3,238,629 0.70%

Profile

since

Note